Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).
Not yet recruitingNCT06974084
HealthBio, Inc.Long COVID
Start: 2025-09-01End: 2026-04-30Target: 252Updated: 2025-05-15